Skip to main content
. 2019 Jan 15;2019:7120169. doi: 10.1155/2019/7120169

Table 6.

GRADE evidence profile.

Certainty assessment No. of patients Effect Certainty
No. of studies Study design Risk of bias Inconsistency Indirectness Imprecision Other considerations APT Control Relative
(95% CI)
Absolute
(95% CI)
Global score on PSQI
9 Randomized trials Seriousa Seriousb Not serious Not serious None 282 284 - SMD 1.13 lower
(1.48 lower to 0.78 lower)
⨁⨁◯◯ 
LOW
Effective rate
13 Randomized trials Seriousa Not serious Not serious Not serious None 350/407 
(86.0%)
277/409 
(67.7%)
RR 1.24
(1.13 to 1.36)
163 more per 1,000
(from 88 more to 244 more)
⨁⨁⨁◯ 
MODERATE
Adverse events
3 Randomized trials Seriousa Seriousb Not serious Seriousc None 3/110 
(2.7%)
22/113 
(19.5%)
RR 0.19
(0.01 to 2.89)
158 fewer per 1,000
(from 193 fewer to 368 more)
◯◯◯ 
VERY LOW

GRADE: Grading of Recommendations Assessment, Development and Evaluation; APT: auricular plaster therapy; PSQI: Pittsburgh Sleep Quality Index; CI: confidence interval; SMD: standardized mean difference; RR: risk ratio.

GRADE Working Group grades of evidence: high quality: further research is very unlikely to change our confidence in the estimate of effect; moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate; low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate; very low quality: we are very uncertain about the estimate.

aMost information is from studies at significant risk of bias (Figure 2). Potential limitations are likely to lower confidence in the estimate of effect.

bSubstantial heterogeneity in results remains unexplained.

c95% CI is wide enough that they overlaps no effect (i.e., 95% CI includes RR of 1.0).